These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 16441208)

  • 1. Developments towards effective treatments for Nipah and Hendra virus infection.
    Bossart KN; Broder CC
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
    Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
    Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Henipavirus pathogenesis and antiviral approaches.
    Mathieu C; Horvat B
    Expert Rev Anti Infect Ther; 2015 Mar; 13(3):343-54. PubMed ID: 25634624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hendra and Nipah viruses: pathogenesis and therapeutics.
    Eaton BT; Broder CC; Wang LF
    Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A treatment for and vaccine against the deadly Hendra and Nipah viruses.
    Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF
    Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of henipavirus infection: a review.
    Weingartl HM; Berhane Y; Czub M
    Vet J; 2009 Sep; 181(3):211-20. PubMed ID: 19084436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization strategies against henipaviruses.
    Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
    Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate-dependent enhancement of henipavirus infection.
    Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
    mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Hendra and Nipah virus infection in humans.
    Escaffre O; Borisevich V; Rockx B
    J Infect Dev Ctries; 2013 Apr; 7(4):308-11. PubMed ID: 23592639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus.
    Berhane Y; Berry JD; Ranadheera C; Marszal P; Nicolas B; Yuan X; Czub M; Weingartl H
    J Virol Methods; 2006 Mar; 132(1-2):59-68. PubMed ID: 16226320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Henipavirus: a review of laboratory animal pathology.
    Williamson MM; Torres-Velez FJ
    Vet Pathol; 2010 Sep; 47(5):871-80. PubMed ID: 20682803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models for the study of emerging zoonotic viruses: Nipah and Hendra.
    Horvat B
    Vet J; 2009 Sep; 181(3):207-8. PubMed ID: 19200760
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review.
    Bhattacharya S; Dhar S; Banerjee A; Ray S
    Curr Mol Pharmacol; 2020; 13(2):108-125. PubMed ID: 31657692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virology. A henipavirus vaccine in sight.
    von Messling V; Cattaneo R
    Science; 2012 Aug; 337(6095):651-2. PubMed ID: 22879489
    [No Abstract]   [Full Text] [Related]  

  • 16. Containing the contagion: treating the virus that inspired the film.
    Lee B
    Sci Transl Med; 2011 Oct; 3(105):105fs6. PubMed ID: 22013121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hendra and Nipah viruses: why are they so deadly?
    Marsh GA; Wang LF
    Curr Opin Virol; 2012 Jun; 2(3):242-7. PubMed ID: 22483665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hendra and Nipah infection: emerging paramyxoviruses.
    Aljofan M
    Virus Res; 2013 Nov; 177(2):119-26. PubMed ID: 23954578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nipah and Hendra virus infectious diseases].
    Yoneda M
    Nihon Rinsho; 2016 Dec; 74(12):1973-1978. PubMed ID: 30550652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
    Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC
    J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.